Inventor · disambiguated record
Haiqing Yuan
Also filed as: YUAN HAIQING
39 granted patents·11 pending applications·114 citations·filing 2002–2024
97Inventor score
Files withALLERGAN INC28YUAN HAIQING8SUZHOU ARK BIOPHARMACEUTICAL CO LTD7BEARD RICHARD L4SHANGHAI ARK BIOPHARMACEUTICAL CO LTD3
Top patents by PatentIndex Score
50 records- 0193US8097644B2Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonistBEARD RICHARD L·Filed 2007·Granted Jan 17, 2012·12 cites·7 claims
- 0290US8791161B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Jul 29, 2014·7 cites·14 claims
- 0389US8927544B2Benzofuran-2-sulfonamides derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Jan 6, 2015·4 cites·6 claims
- 0487US8450367B2Sulfur derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted May 28, 2013·7 cites·16 claims
- 0587US7737173B2Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activityALLERGAN INC·Filed 2007·Granted Jun 15, 2010·6 cites·3 claims
- 0686US8815915B2Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Aug 26, 2014·3 cites·12 claims
- 0785US7728014B2Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activityALLERGAN INC·Filed 2007·Granted Jun 1, 2010·4 cites·7 claims
- 0884US8822530B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Sep 2, 2014·3 cites·14 claims
- 0983US8877804B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Nov 4, 2014·3 cites·2 claims
- 1082US6864282B29,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucomaALLERGAN INC·Filed 2002·Granted Mar 8, 2005·24 cites·37 claims
- 1181US9371278B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted Jun 21, 2016·2 cites·13 claims
- 1281US9328067B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted May 3, 2016·2 cites·7 claims
- 1381US8518913B2Phosphorous derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted Aug 27, 2013·3 cites·14 claims
- 1480US8580779B21,2-bis-sulfonamide derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted Nov 12, 2013·4 cites·5 claims
- 1579US6759546B13,5-di-iso-propyl-heptatrienoic acid derivatives having serum glucose reducing activityALLERGAN INC·Filed 2003·Granted Jul 6, 2004·11 cites·17 claims
- 1678US11046644B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2019·Granted Jun 29, 2021·0 cites·6 claims
- 1778US9416120B2Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted Aug 16, 2016·1 cites·8 claims
- 1878US8012992B2Aza-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activityALLERGAN INC·Filed 2009·Granted Sep 6, 2011·2 cites·9 claims
- 1977US10287243B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2015·Granted May 14, 2019·1 cites·9 claims
- 2077US9663460B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted May 30, 2017·1 cites·13 claims
- 2177US8524917B26-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activityBEARD RICHARD L·Filed 2008·Granted Sep 3, 2013·2 cites·14 claims
- 2276US8536339B2AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activityYUAN HAIQING·Filed 2011·Granted Sep 17, 2013·2 cites·4 claims
- 2376US8263767B2AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activityYUAN HAIQING·Filed 2011·Granted Sep 11, 2012·2 cites·9 claims
- 2474US8614326B2Therapeutic quinoline and naphthalene derivativesBEARD RICHARD L·Filed 2008·Granted Dec 24, 2013·1 cites·14 claims
- 2574US8524745B2Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2012·Granted Sep 3, 2013·2 cites·14 claims
- 2671US6759547B15,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activityALLERGAN INC·Filed 2003·Granted Jul 6, 2004·5 cites·24 claims
- 2762US8729066B21,2- bis-sulfonamide derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted May 20, 2014·0 cites·11 claims
- 2862US2014221351A1Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 2960US9550746B2Benzofuran-2-sulfonamides derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2015·Granted Jan 24, 2017·0 cites·4 claims
- 3056US2025215020A1Compounds as elastase inhibitor and method of preparing the sameSHANGHAI ARK BIOPHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 3155US2025213598A1Compounds as elastase inhibitor and solid form thereofSHANGHAI ARK BIOPHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 3254US9603834B21,2- bis-sulfonamide derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2015·Granted Mar 28, 2017·0 cites·11 claims
- 3353US8404863B2Tetrahydroindoles having sphingosine-1-phosphate receptor activityYUAN HAIQING·Filed 2008·Granted Mar 26, 2013·0 cites·10 claims
- 3452US7888336B2Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activityALLERGAN INC·Filed 2008·Granted Feb 15, 2011·0 cites·6 claims
- 3552US2014107153A1Therapeutic quinoline and naphthalene derivativesALLERGAN INC·Filed 2013·Application pending·0 cites
- 3651US2023293500A1Ak3287 preparation, and preparation method therefor and application thereofSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3750US10717730B1Dihydroisoquinoline compoundSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 21, 2020·0 cites·6 claims
- 3850US9670190B2Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted Jun 6, 2017·0 cites·13 claims
- 3949US12365699B2Elastase inhibitor prodrug and use thereofSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2021·Granted Jul 22, 2025·0 cites·20 claims
- 4049US2025026742A1Compound as atr kinase inhibitorSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 4147US2015152080A1Benzothiophene sulfonamides derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 4246US2023295159A1Atx inhibitor, and preparation method therefor and use thereofSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 4343US2019211003A1Novel 16-member triamilide derivatives and uses thereofYUAN HAIQING·Filed 2019·Application pending·0 cites
- 4442US6887896B17-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activityALLERGAN INC·Filed 2003·Granted May 3, 2005·0 cites·68 claims
- 4542US2022387443A1Respiratory syncytial virus fusion protein inhibitor compositions and methods for the treatment and prophylaxis of rsv diseases using the sameSHANGHAI ARK BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 4640US6884820B25,6,7,8-tetrahydronaphthalen-2-yl-7-fluoroalkyl-heptatrienoic acid derivatives having serum glucose reducing activityALLERGAN INC·Filed 2003·Granted Apr 26, 2005·0 cites·20 claims
- 4739US10647712B2Dihydroisoquinoline compoundSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted May 12, 2020·0 cites·26 claims
- 4839US8143291B2Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activityBEARD RICHARD L·Filed 2011·Granted Mar 27, 2012·0 cites·7 claims
- 4939US2022081434A1Dihydroisoquinoline compoundSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 5038US10287275B216-member triamilide derivatives and uses thereofYUAN HAIQING·Filed 2015·Granted May 14, 2019·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Haiqing Yuan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →